211
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Role of p53 Protein and MMP-2 Tumor/Stromal Cells Expression on Progressive Growth of Ovarian Neoplasms

&
Pages 472-479 | Received 20 Nov 2012, Accepted 25 Jun 2013, Published online: 05 Aug 2013

REFERENCES

  • Cai J, Tang H, Xu L, Wang X, Yang C, Ruan S, Guo J, Hu S, Wang Z. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis 2012;33(1):20–29.
  • Mury D, Woelber L, Jung S, Eulenburg C, Choschzick M, Witzel I, Schwarz J, Jaenicke F, Mahner S. Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer. J Cancer Res Clin Oncol 2011;137(7):1131–1137.
  • Molloy T, van't Veer LJ. Recent advances in metastasis research. Curr Opin Genet Dev 2008;18(1):35–41.
  • Quintavalle M, Elia L, Condorelli G, Courtneidge SA. MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 2010;189(1):13–22.
  • Kenny HA, Kaur S, Coussens LM, Lengyel E. The initial steps of ovarian cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008;118(4):1367–1379.
  • Lin CK, Chao TK, Yu CP, Yu MH, Jin JS. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters. APMIS 2009;117(3):162–175.
  • Krypuy M, Ahmed AA, Etermadmoghadam D, Hyland SJ, Australian Ovarian Cancer Study Group, DeFazio A, Fox SB, Brenton JD, Bowtell DD, Dobrovic A. High resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer 2007;7:168.
  • Ahmed N, Thompson EW, Quinn MA. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 2007;213(3):581–588.
  • Mendoza M, Khanna C. Revisting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 2009;41(7):1452–1462.
  • Xia M, Land H. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol 2007;14(3):215–223.
  • Wang SP, Wang WL, Chang YL, Wu CT, Chao YC, Kao SH, Yuan A, Lin CW, Hong TM, Yang PC. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 2009;11(6):694–704.
  • Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S. p53 abnormality and tumor invasion in patients with malignant astrocytoma. Brain Tumor Pathol 2010;27(2):95–101.
  • Kenny HA, Lengyel E. MMP-2 functions as an early response protein in ovarian cancer. Cell Cycle 2009;8(5):683–688.
  • Maatta M, Santala M, Soini Y, Talvensaari-Mattila A, Turpeenniemi-Hujanen T. Matrix metalloproteinases 2 and 9 their tissue inhibitors in low malignant potential ovarian tumors. Tumor Biol 2004;25(4):188–192.
  • Zhou CX, Gao Y, Johnson NW, Gao J. Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue. Aus Dent J 2010;55(4):385–389.
  • Perigny M, Bairati I, Harvey I, Beauchemin M, Harel F, Plante M, Tetu B. Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer. Am J Clin Pathol 2008;129(2):226–231.
  • Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Partridge EE, Lillard JW Jr. CCL25-CCR9 interaction modulates ovarian cancer cell migration metalloproteinase expression, and invasion. World J Surg Oncol 2010;22(8):62.
  • Sillanpaa S, Anttila M, Suhonen K, Hamalainen K, Turpeenniemi-Hujanen T, Puistola U, Tammi M, Sironen R, Saarikoski S, Kosma VM. Prognostic significance of extracellular matrix metalloproteinases inducer and matrix matalloproteinases 2 in epithelial ovarian cancer. Tumor Biol 2007;28(5):280–289.
  • Kamat AA, Fletcher M, Gruman LM, Mueller P, Lopez A, Landen CN Jr., Han L, Gershenson DM, Sood AK. The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clin Cancer Res 2006;12(6):1707–1714.
  • Arik D, Kulacoglu S. p53, bcl-2, and nm23 expression in serous ovarian tumors: correlation with the clinical and histopathological parameters. Turk Patoloji Derg 2011;27(1):38–45.
  • Rojiani MV, Alidina J, Esposito N, Rojiani AM. Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp Pathol 2010;3(8):775–781.
  • Olson ES, Aguilera TA, Jiang T, Ellies LG, Nguyen QT, Wong EH, Gross LA, Tsieh RY. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) 2009;1(5–6):382–393.
  • Muller PAJ, Vousden KH, Norman JC. p53 and its mutants in tumor cell migration and invasion. J Cell Biol 2011;192(2):209–218.
  • Delassus GS, Cho H, Hoang S, Eliceiri GL. Many new down- and up-regulatory signaling pathways, from known cancer progression suppressors to matrix metalloproteinases, differ widely in cells of various cancers. J Cell Physiol 2010;224(2):549– 558.
  • Staun-Ram E, Goldman S, Shalev E. p53 Mediates epidermal growth factor (EGF) induction of MMP-2 transcription and trophoblast invasion. Placenta 2009;30(12):1029–1036.
  • Chen NH, Zhong JJ. p53 is important for the anti-invasion of ganoderic acid T in human carcinoma cells. Phytomedicine 2011;18(8–9):719–725.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.